Contact this trialFirst, we need to learn more about you.
Alkylating agents
Chemotherapy and Radiation Based on EBV DNA for Nasopharyngeal Cancer
Recruiting1 awardPhase 2 & 3
Portsmouth, Virginia
This trial will test whether a blood biomarker can help doctors identify which patients will benefit from different types of chemotherapy after radiation therapy for nasopharyngeal cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.